Eurobio Scientific SA
PAR:ALERS
Eurobio Scientific SA
PAR:ALERS
Price:
21.4
EUR
-4.46%
Market Closed
Market Cap:
€219.4m
Balance Sheet
Balance Sheet Decomposition
Eurobio Scientific SA
Eurobio Scientific SA
Balance Sheet Decomposition is not available for
Eurobio Scientific SA
Eurobio Scientific SA
Balance Sheet
Eurobio Scientific SA
Eurobio Scientific SA
Currency: EUR
| Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||
| Cash & Cash Equivalents |
27
|
17
|
17
|
14
|
24
|
31
|
21
|
30
|
26
|
13
|
10
|
6
|
14
|
12
|
8
|
12
|
11
|
8
|
66
|
102
|
86
|
89
|
23
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
6
|
6
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
27
|
17
|
17
|
14
|
24
|
25
|
15
|
28
|
26
|
13
|
10
|
6
|
14
|
12
|
8
|
12
|
11
|
8
|
66
|
102
|
86
|
89
|
23
|
|
| Total Receivables |
0
|
1
|
0
|
0
|
2
|
2
|
5
|
3
|
3
|
3
|
7
|
8
|
7
|
7
|
7
|
11
|
11
|
22
|
55
|
54
|
40
|
32
|
37
|
|
| Accounts Receivables |
0
|
1
|
0
|
0
|
2
|
1
|
1
|
1
|
1
|
1
|
4
|
6
|
5
|
4
|
5
|
8
|
8
|
17
|
52
|
44
|
33
|
27
|
32
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
4
|
2
|
2
|
2
|
3
|
2
|
3
|
3
|
2
|
3
|
3
|
5
|
3
|
9
|
7
|
5
|
5
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
2
|
2
|
2
|
7
|
9
|
9
|
13
|
16
|
22
|
21
|
27
|
|
| Other Current Assets |
1
|
2
|
2
|
3
|
3
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
1
|
1
|
2
|
3
|
|
| Total Current Assets |
29
|
19
|
18
|
17
|
29
|
34
|
27
|
34
|
29
|
17
|
19
|
16
|
24
|
21
|
19
|
31
|
32
|
40
|
135
|
174
|
149
|
144
|
90
|
|
| PP&E Net |
5
|
4
|
3
|
2
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
4
|
5
|
8
|
10
|
10
|
13
|
12
|
13
|
|
| PP&E Gross |
5
|
4
|
3
|
2
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
4
|
5
|
8
|
10
|
10
|
13
|
12
|
13
|
|
| Accumulated Depreciation |
2
|
2
|
3
|
4
|
4
|
5
|
5
|
6
|
6
|
6
|
9
|
7
|
7
|
8
|
6
|
7
|
9
|
10
|
10
|
13
|
16
|
22
|
28
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
1
|
13
|
12
|
11
|
9
|
12
|
10
|
8
|
6
|
4
|
39
|
37
|
36
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
17
|
3
|
2
|
2
|
2
|
24
|
22
|
23
|
21
|
18
|
116
|
116
|
117
|
|
| Long-Term Investments |
3
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
5
|
3
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
3
|
1
|
4
|
14
|
7
|
1
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
17
|
3
|
2
|
2
|
2
|
24
|
22
|
23
|
21
|
18
|
116
|
116
|
117
|
|
| Total Assets |
36
N/A
|
28
-23%
|
26
-8%
|
22
-14%
|
33
+46%
|
38
+15%
|
30
-21%
|
37
+22%
|
31
-14%
|
18
-44%
|
38
+119%
|
33
-13%
|
40
+21%
|
36
-12%
|
32
-11%
|
72
+124%
|
70
-2%
|
81
+16%
|
172
+113%
|
210
+22%
|
331
+58%
|
316
-4%
|
257
-19%
|
|
| Liabilities | ||||||||||||||||||||||||
| Accounts Payable |
1
|
1
|
2
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
4
|
4
|
5
|
5
|
5
|
9
|
7
|
9
|
7
|
7
|
13
|
13
|
15
|
|
| Accrued Liabilities |
1
|
2
|
1
|
1
|
2
|
2
|
2
|
1
|
2
|
1
|
3
|
3
|
3
|
2
|
1
|
3
|
3
|
3
|
5
|
7
|
10
|
6
|
6
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
1
|
8
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
4
|
7
|
8
|
8
|
15
|
4
|
15
|
15
|
3
|
|
| Other Current Liabilities |
3
|
1
|
1
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
3
|
2
|
1
|
3
|
6
|
6
|
6
|
11
|
20
|
17
|
19
|
19
|
20
|
|
| Total Current Liabilities |
6
|
5
|
12
|
5
|
5
|
5
|
6
|
4
|
4
|
3
|
11
|
11
|
10
|
10
|
16
|
25
|
24
|
32
|
48
|
36
|
57
|
53
|
44
|
|
| Long-Term Debt |
2
|
1
|
4
|
0
|
14
|
14
|
14
|
7
|
7
|
0
|
2
|
2
|
8
|
6
|
2
|
14
|
15
|
11
|
15
|
11
|
99
|
86
|
31
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
2
|
1
|
2
|
2
|
3
|
2
|
2
|
3
|
3
|
3
|
2
|
2
|
2
|
2
|
3
|
|
| Total Liabilities |
8
N/A
|
6
-24%
|
15
+146%
|
6
-62%
|
19
+226%
|
20
+1%
|
20
+3%
|
11
-45%
|
12
+9%
|
4
-67%
|
15
+267%
|
14
-7%
|
21
+49%
|
19
-10%
|
21
+10%
|
41
+100%
|
42
+1%
|
46
+10%
|
65
+42%
|
49
-24%
|
158
+221%
|
141
-11%
|
78
-44%
|
|
| Equity | ||||||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
3
|
3
|
4
|
4
|
4
|
4
|
4
|
3
|
|
| Retained Earnings |
19
|
25
|
36
|
40
|
45
|
53
|
61
|
69
|
77
|
84
|
90
|
96
|
101
|
107
|
114
|
124
|
128
|
125
|
63
|
117
|
129
|
138
|
155
|
|
| Additional Paid In Capital |
47
|
47
|
47
|
56
|
58
|
70
|
71
|
94
|
95
|
97
|
112
|
114
|
120
|
123
|
125
|
152
|
153
|
156
|
40
|
40
|
40
|
34
|
20
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
28
N/A
|
22
-22%
|
10
-52%
|
16
+56%
|
13
-19%
|
18
+37%
|
10
-46%
|
25
+161%
|
19
-25%
|
14
-29%
|
24
+74%
|
20
-17%
|
20
+2%
|
17
-14%
|
11
-34%
|
30
+168%
|
28
-7%
|
35
+25%
|
107
+204%
|
161
+50%
|
173
+8%
|
175
+1%
|
179
+2%
|
|
| Total Liabilities & Equity |
36
N/A
|
28
-23%
|
26
-8%
|
22
-14%
|
33
+46%
|
38
+15%
|
30
-21%
|
37
+22%
|
31
-14%
|
18
-44%
|
38
+119%
|
33
-13%
|
40
+21%
|
36
-12%
|
32
-11%
|
72
+124%
|
70
-2%
|
81
+16%
|
172
+113%
|
210
+22%
|
331
+58%
|
316
-4%
|
257
-19%
|
|
| Shares Outstanding | ||||||||||||||||||||||||
| Common Shares Outstanding |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
3
|
3
|
3
|
4
|
4
|
10
|
10
|
11
|
11
|
11
|
11
|
10
|
10
|
|
Switch to:
Switch to:
See Also
Discover More
